Share it on:
Company Overview
Founded in 2015, PharmEasy is a leading online healthcare platform in India that provides a range of services, including medicine delivery, diagnostic tests, and telemedicine consultations. The company aims to make healthcare accessible and affordable through technology-driven solutions.
Key Highlights
- Founded: 2015
- Headquarters: Mumbai, India
- Business Model: E-commerce for pharmaceuticals, diagnostics, and healthcare services.
- Key Services:
- Medicine Delivery: Home delivery of prescription and over-the-counter medications.
- Diagnostics: Lab tests conducted at home with online reporting.
- Telemedicine: Online consultations with qualified healthcare professionals.
Financial Performance
- Revenue Growth: PharmEasy has seen significant growth in revenues, reaching approximately ₹1,200 crores in FY 2022, up from ₹500 crores in FY 2021.
- Profitability: The company aims to achieve profitability in the near future by optimizing operations and scaling its service offerings.
Future Plans
- Expansion: PharmEasy plans to expand its services to tier-2 and tier-3 cities to capture a larger customer base.
- Technology Investment: Increased investment in technology to enhance user experience and improve operational efficiencies.
- Partnerships: Forge partnerships with local pharmacies and healthcare providers to expand the product and service range.
- Diversification: Explore new healthcare-related services, such as health insurance and wellness programs.
Fundamentals
| Metric | Value | Metric | Value |
|---|---|---|---|
| Current Price | ₹ 11 | P/B | 1.1 |
| Debt to Equity | 0.57 | P/E Ratio | -3 |
| Market Cap (in Cr.) | ₹ 6756 | PAN Number | AASCA1201E |
| Face Value | 1 | EPS | -3.71 |
| Book Value | 10 | ISIN | INE0DJ201029 |
| ROE (%) | -37.25 | No. Of Shares (in Cr.) | 614.2 |
Promoters & Managements
| Name | Designation |
|---|---|
| Dr. Dhaval Shah | Co-Founder, CBO |
| Siddharth Shah | CEO |
| Abhinav Jain Ranka | CFO |
Balance Sheet
| Assets | 2022 | 2023 |
|---|---|---|
| Fixed Assets | 1025 | 913 |
| CWIP (Capital Work in Progress) | 7.8 | 7 |
| Investments | 438 | 437 |
| Trade Receivables | 861 | 903 |
| Inventory | 761 | 689 |
| Other Assets | 8305.2 | 8393.6 |
| Total Assets | 11398 | 11342.6 |
| Liabilities | 2022 | 2023 |
|---|---|---|
| Share Capital | 614.2 | 614.2 |
| Face Value (FV) | 1 | 1 |
| Reserves | 6408.3 | 5501.4 |
| Borrowings | 2585 | 3511 |
| Trade Payables | 459 | 356 |
| Other Liabilities | 1331.5 | 1360 |
| Total Liabilities | 11398 | 11342.6 |
Cash Flow Statement
| Cash Flow Items | 2022 | 2023 |
|---|---|---|
| Cash Generated From Operations | -2505 | -669 |
| Tax | -84 | -61 |
| Cash Flow From Operations | -2589 | -730 |
| Purchase of PPE | -143 | -92 |
| Sale of PPE | 5 | 4 |
| Cash Flow From Investment | -5789 | -100 |
| Borrowing | 2016 | 648 |
| Dividend | 0 | 22.8 |
| Equity | 6344 | 548 |
| Other Financing | -55 | -363 |
| Cash Flow from Financing | 8305 | 855.8 |
| Net Cash Generated | -73 | 25.8 |
| Cash at the Start | 230 | 157 |
| Cash at the End | 157 | 182.8 |
Share Holding Pattern
| Shareholder | 2022 | 2023 |
|---|---|---|
| Naspers Ventures B.V. | 13.24% | 13.24% |
| Evermed Holdings Pte. Ltd | 6.45% | 6.45% |
| MacRitchie Investments Pte. Ltd | 11.93% | 11.93% |
Frequently Asked Questions (FAQ)
Find answers to common questions, providing clarity and insights to address any queries on your mind.
Contact Us: Reach out to Unlistify to confirm availability and agree on a price.
Provide KYC: Submit your Client Master Report, PAN card, and a cancelled cheque.
Make Payment: Transfer funds to our designated bank account (RTGS/NEFT/IMPS/cheque). Ensure the payment originates from the same account where you want the shares credited.
Receive Shares: We’ll transfer the shares to your Demat account within 24 hours of payment confirmation.
Get a Quote: Unlistify will provide a buyback price for your holding shares.
Share Details: Submit your Client Master Report.
Transfer Shares: Transfer the said shares to our Demat account using a DIS (Delivery Instruction Slip).
Receive Payment: We’ll transfer funds to your bank account within 24 hours of receiving the shares (RTGS/NEFT/IMPS/cheque). For security reasons, payment will only be made to the account linked to your Demat
DIS (Delivery Instruction Slip): A DIS is a form used to authorize the transfer of shares from your Demat account.
Methods:
Offline DIS: Fill out a physical DIS form with details like the ISIN number, quantity, price of your shares, and our account information. Submit this to your broker.
Online DIS: Some brokers offer online DIS systems for easier transfers.
Unlistify aims to make unlisted share investing accessible. The current minimum investment for Unlisted Shares is approximately 35,000 – 50,000 INR. It will also vary as per shares because every share has a different price.
Limited Liquidity: Unlisted shares are not traded on public exchanges, making it potentially harder to find buyers when you want to sell.
Price Volatility: Prices can fluctuate more than listed shares due to less publicly available information.
Regulatory Changes: Regulations for unlisted shares can change, affecting their value and trading.
Company-Specific Risks: Each company has its own risks related to its industry, financials, and management.
No Guarantee of Listing: There’s no assurance that unlisted shares will ever be listed on a public exchange.
Market Leader: Unlistify is one of India’s fastest-growing unlisted share platforms.
Transparency: We provide clear information about each unlisted share, including potential risks.
Security: We prioritize the protection of your financial information.
Customer Support: Our team is dedicated to guiding you through the investment process.
Latest Funding: We consider the valuation from most recent funding round.
Comparable Companies: If there’s no recent funding, we analyze similar listed companies to estimate a fair value.
SEBI’s Influence: SEBI regulations do apply to some aspects of unlisted share trading, such as lock-in periods and transaction charges. However, there are no specific SEBI regulations for becoming an unlisted broker.
We aim for same-day transfer of Unlisted Shares to your Demat account after your payment is confirmed.
Tax Transition: Once your unlisted shares are listed and sold on an exchange, standard listed share tax rules apply.
Holding Period: Your holding period (for determining long-term vs. short-term capital gains tax) starts from the original unlisted purchase date.
